scholarly journals Assessment of renal function and acute rejection using Cystatin C and kidney injury Molecule-1 in renal transplant recipients

2018 ◽  
Vol 12 (1) ◽  
pp. 53
Author(s):  
Sailaja Kesiraju ◽  
LakshmiKiran Chelluri ◽  
Sumanlatha Gaddam ◽  
VijayaLakshmi Valluri ◽  
UmaMaheswara Rao Ch ◽  
...  
Keyword(s):  
Renal Function ◽  
Renal Transplant ◽  
Acute Rejection ◽  
Cystatin C ◽  
Kidney Injury ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Kidney Injury Molecule 1

Urinary Excretion of Kidney Injury Molecule -1 in Renal Transplant Recipients

2012 ◽  
Vol 94 (10S) ◽  
pp. 1166
Author(s):  
S. Kesiraju ◽  
P. Paritala ◽  
C. Uma Maheswara Rao ◽  
A. S. Murthy ◽  
V. S. Reddy ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Urinary Excretion ◽  
Kidney Injury ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Kidney Injury Molecule 1

Evaluation of Renal Function By Cystatin C in Renal Transplant Recipients

2014 ◽  
Vol 12 (1) ◽  
pp. 37-40
Author(s):  
Salma Ayub ◽  
◽  
Mirza Naqi Zafar ◽  
Tahir Aziz ◽  
Tanweer Iqbal ◽  
...  
Keyword(s):  
Renal Function ◽  
Renal Transplant ◽  
Cystatin C ◽  
Renal Transplant Recipients ◽  
Transplant Recipients

scholarly journals High Urinary Excretion of Kidney Injury Molecule-1 Is an Independent Predictor of Graft Loss in Renal Transplant Recipients

2007 ◽  
Vol 84 (12) ◽  
pp. 1625-1630 ◽  
Author(s):  
Mirjan M. van Timmeren ◽  
Vishal S. Vaidya ◽  
Rutger M. van Ree ◽  
Leendert H. Oterdoom ◽  
Aiko P. J. de Vries ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Urinary Excretion ◽  
Independent Predictor ◽  
Graft Loss ◽  
Kidney Injury ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
High Urinary Excretion ◽  
Kidney Injury Molecule 1

Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?

Nephrology ◽  
2008 ◽  
Vol 13 (3) ◽  
pp. 251-255 ◽  
Author(s):  
CHI YUEN CHEUNG ◽  
YAN LUN LIU ◽  
KIM MING WONG ◽  
HOI WONG CHAN ◽  
YIU HAN CHAN ◽  
...  
Keyword(s):  
Renal Function ◽  
Renal Transplant ◽  
Acute Rejection ◽  
Renal Transplant Recipients ◽  
Transplant Recipients

Renal Function following Conversion from Sandimmune to Neoral in Stable Renal Transplant Recipients

1997 ◽  
Vol 7 (2) ◽  
pp. 78-81
Author(s):  
Marilyn R Bartucci ◽  
Bernadette Koshla ◽  
Sandra Fleming-Brooks ◽  
Kelly Weigel ◽  
Vicki Donley ◽  
...  
Keyword(s):  
Renal Function ◽  
Renal Transplant ◽  
Acute Rejection ◽  
Multivariate Analyses ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Short Term ◽  
Entire Cohort ◽  
Transplant Patients ◽  
Serial Serum

Conversion of stable renal transplant patients from Sandimmune to Neoral may pose a risk of short-term nephrotoxicity. Serial serum creatinine concentrations were measured in 141 kidney and simultaneous kidney-pancreas transplant recipients converted from Sandimmune to Neoral on a 1:1 dosing basis and followed for up to 11 months. Following conversion, cyclosporine dose was reduced in 74% of patients with a mean dose reduction of 22.6% for the entire cohort. Serum create-nine concentrations transiently increased to more than 30% above baseline in 48% of patients and remained more than 30% above baseline in 16% of patients. Multivariate analyses suggested that acute rejection, maintenance steroid therapy, young age, Sandimmune dose prior to conversion, and an increment in trough cyclosporine levels after conversion were positive predictors of renal insufficiency following conversion. Lower doses of Neoral should be considered at the time of conversion to minimize nephrotoxicity.

Sign in / Sign up

Export Citation Format

Share Document